Washington [US], July 28 (ANI): A new class of glioma medications takes advantage of tumours lacking the DNA repair enzyme MGMT; the medications cause the generation of cytotoxic DNA and kill tumour cells specifically without the risk of developing resistance, according to research.
Bangalore (Karnataka) [India], July 25 (ANI/BusinessWire India): World over, uterine fibroids are one of the most common benign tumours affecting women of all races, sometimes up to 80 per cent, depending on the age of a patient, according to a study by the Journal of Obstetrics and Gynaecol
Washington [US], July 25 (ANI): A study revealed that tumors are made up of many different cell types, including both cancerous and benign. The unique intricacy of the cells found inside brain tumours has been a defining feature of the condition, one that makes therapy very challenging. Alth
Boston [US], July 22 (ANI): Using nanoparticles to deliver cancer drugs allows for high drug concentrations to be delivered to tumours while avoiding the harmful side effects associated with chemotherapy. However, only a few nanoparticle-based cancer drugs have received FDA approval.
California [US], June 30 (ANI): According to a new study, CD8+ T cells which are activated in response to infections and tumours and are able to recall the names of harmful invaders, are receiving more attention from researchers studying how the human immune system reacts to pathogens and ca
Ann Arbor [Michigan], June 29 (ANI): Numerous cell types, including both malignant and benign cells, make up tumours. One distinctive feature of the condition that makes therapy exceedingly challenging is the particular intricacy of the cells found inside brain tumours. Despite the fact that
Winston (North Carolina) [US], June 19 (ANI): According to a recent study, a group of Wake Forest University School of Medicine researchers found a new way of treating solid tumours with the creation of a novel nanoparticle. They also discovered that cancers of breast, colon, head and nec
Los Angeles [US], June 19 (ANI): According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.
Los Angeles [US], June 17 (ANI): According to a team led by UCLA in collaboration with scientists from Stanford and the University of Pennsylvania, has demonstrated that a synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
Winston (North Carolina) [US], June 16 (ANI): Researchers from Wake Forest University School of Medicine in the US North Carolina have discovered a possible new approach to treating solid tumours through the creation of a novel nanoparticle. Solid tumours are found in cancers such as breast,
Washington [US], June 12 (ANI): A new study has found that a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.
New Delhi [India], June 11 (ANI): Days after rectal cancer vanished without the need for the conventional therapies in patients who received immunotherapy during a clinical trial, Paras Hospitals, Gurugram, Oncology Chairman Dr. (Col.) R. Ranga Rao on Saturday said that it is not right to pr